2.5 Points Of EPS Growth Nearly Double My Palantir Valuation

Palantir reported 96% revenue growth and a 47% GAAP operating margin, with U.S. commercial revenue now exceeding U.S. government revenue. The article flags a 52x forward-sales valuation, sluggish international commercial growth, decelerating customer signings, and execution and competitive risks, including from Anthropic.

Analysis

The key risk is not that current profitability is weak; it is that the valuation makes the stock unusually sensitive to any evidence that growth is becoming harder to reproduce. Decelerating signings matter more than strong expansion within existing accounts if they signal weaker new-logo formation: that would challenge the durability of growth before it necessarily appears in reported revenue. A senior-led sales model also creates a scaling constraint—rep productivity and sales capacity become the test of whether customer demand can translate into repeatable growth.

The competitive risk from Anthropic is not automatically a zero-sum displacement. If customers use competing models through Palantir’s software, model choice could support adoption; if model providers capture more of the application and workflow layer, it could weaken Palantir’s pricing power. The distinction is product-level and should be verified, not inferred from partnership or competition headlines.

Over the next 1–3 months, signings, new-customer additions, pilot conversions, and forward guidance are more useful than trailing growth for testing the thesis. Over 6–18 months, international commercial traction and evidence that sales productivity scales determine whether premium valuation can persist. The contrarian case is that high margins and customer expansion may absorb a moderate slowdown; a valuation-based short alone is premature without confirmed deterioration. Falsifiers for the bearish case: reaccelerating signings, broader international wins, or guidance that holds despite slower bookings. Verify the definitions and period comparability behind the reported growth and margin figures before modeling them.

Key Decisions for Investors

• Avoid initiating an outright short solely on valuation. Treat PLTR as a high-expectations position and size exposure against the risk of multiple compression if bookings or guidance disappoint.
• Conditional trade: if the next earnings update confirms weaker signings or new-customer growth and the stock reacts by failing to recover its post-report level, consider a defined-risk PLTR put spread rather than an unhedged short. Check option pricing and liquidity first; the thesis is invalidated by a clear reacceleration in bookings or guidance.
• Track new-logo additions, pilot-to-production conversion, sales productivity, and international commercial growth as 1–3 month indicators; reported revenue can lag a deterioration in demand.
• Do not assume Anthropic’s model competition directly displaces PLTR. Monitor customer product choices and any evidence of changes in Palantir’s pricing, deployment scope, or expansion rates before expressing a relative-value trade.